Theodore J Kottom

14PUBLICATIONS
6CO-AUTHORS
Medical infection agents (incl. prions)Medical mycologyCheminformatics and quantitative structure-activity relationshipsPharmacogenomicsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 24, 2026
The Tyrosine Kinase Receptor EphA2 in Alveolar Macrophages Provides a Protective Role in Host Defense Against Pneumocystis Pneumonia.

|Nov 20, 2025
Global prevalence of multidrug-resistant Candida auris in humans between 2015 and 2024: A systematic review and meta-analysis.

Conrad C Achilonu, Will J Barwatt, Theodore J Kottom

|Oct 06, 2025
Modulation of host lung immunity in Pneumocystis pneumonia: a review of current concepts and future prospects for novel adjunctive immune-based therapies.

Theodore J Kottom, Andrew H Limper

|Jul 16, 2025
The Maximum-Tolerated Dose and Pharmacokinetics of ISFP10 a Novel Inhibitor of Fungal Phosphoglucomutase (PGM).

Theodore J Kottom, Andrew H Limper

|Aug 06, 2024
Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2).

Theodore J Kottom, Kimberly E Stelzig, Madeline R Pellegrino

|Feb 08, 2024
The intestinal commensal fungus Wallemia mellicola enhances asthma in mice through Dectin-2.

Amjad N Kanj, Irene Riestra Guiance, Theodore J Kottom

Pageof 3

Frequent Collaborators

5 joint publications

Andrew H Limper

1 joint publications

Malay Choudhury

1 joint publications

Amjad N Kanj

1 joint publications

Rita O Oladele